8-K: BiomX Announces 1-for-19 Reverse Stock Split

BiomX Inc. will implement a one-for-nineteen reverse stock split of its common stock, effective November 25, 2025, to boost its per-share price.

Summary

• BiomX Inc. will effect a one-for-nineteen (1:19) reverse stock split of its common stock.
• The Board of Directors approved the split on November 13, 2025, following stockholder approval on October 16, 2025.
• The reverse stock split is scheduled to become effective at 12:01 a.m. Eastern Time on November 25, 2025.
• Shares are expected to begin trading on the NYSE American on a split-adjusted basis at the start of trading on November 25, 2025.
• Every nineteen shares of existing common stock will be converted into one new share of common stock.
• Fractional shares resulting from the split will be rounded up to the next whole share.
• The total number of authorized shares, rights, preferences, or par value of the common stock will not be affected.
• Outstanding equity awards, warrants, and convertible preferred stock will be proportionally adjusted.

Sentiment

Score: 3

Explanation: A reverse stock split is generally viewed negatively as it often indicates a company's struggle to maintain its stock price and exchange listing. While it addresses a technical issue, it doesn't improve fundamentals. The rounding up of fractional shares is a minor positive.

Positives

• Fractional shares will be rounded up to the next whole share, benefiting stockholders who would otherwise receive fractional shares.
• The action aims to increase the per-share price, potentially helping the company maintain its listing on the NYSE American.

Negatives

• A reverse stock split often signals a company's struggle to maintain its share price above exchange minimums, indicating underlying financial or operational challenges.
• While the total value of holdings remains the same, the reduction in the number of outstanding shares can sometimes be perceived negatively by the market.

Risks

• Forward-looking statements regarding the effective date and trading on a split-adjusted basis are subject to inherent uncertainties, risks, and changes in circumstances.
• Investors should review the risks and uncertainties described in BiomX's Annual Report on Form 10-K filed on March 25, 2025, and other SEC filings.

Future Outlook

The company expects the reverse stock split to become effective at 12:01 a.m. Eastern Time on November 25, 2025, with split-adjusted trading on the NYSE American commencing at the start of trading on the same day.

Management Comments

• Forward-looking statements are based only on BiomX management's current beliefs, expectations and assumptions.

Industry Context

Reverse stock splits are a common corporate action, particularly for companies whose stock price has fallen significantly, often below the minimum bid price required by exchanges like the NYSE American. This move is typically aimed at increasing the per-share price to meet listing requirements and improve market perception, though it does not change the company's underlying valuation or fundamentals.

Comparison to Industry Standards

• Reverse stock splits are a standard strategy employed by companies across various industries, especially in biotechnology or early-stage growth sectors, when their stock price falls below exchange minimums (e.g., $1.00 per share for NYSE American).
• Many companies, such as Aeterna Zentaris Inc. (AEZS) or Sorrento Therapeutics, Inc. (SRNE), have executed similar reverse stock splits to maintain their exchange listings.
• The 1-for-19 ratio is within the typical range for such actions, often chosen to achieve a target price well above the minimum to provide a buffer.

Corporate Governance

Stakeholder Impact

• Shareholders: Will hold fewer shares, but each share will have a proportionally higher price. Fractional shares will be rounded up to the next whole share. The total value of their holdings should remain the same immediately after the split, but the market perception and future price performance are uncertain.
• Equity Award Holders/Warrant Holders/Convertible Preferred Stock Holders: Their holdings will be proportionally adjusted to reflect the new share count and exercise/conversion prices.

Next Steps

• Filing of the Certificate of Amendment with the Secretary of State of the State of Delaware to effect the Reverse Stock Split.
• The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on November 25, 2025.
• Outstanding shares of Common Stock are expected to begin trading on the NYSE American on a split-adjusted basis at the start of trading on November 25, 2025.
• Continental Stock Transfer & Trust Company will send instructions to stockholders of record holding stock certificates.

Key Dates

Recommendation

While a reverse stock split is often a sign of underlying weakness and can lead to negative market sentiment, it is a necessary corporate action for BiomX to maintain its listing on the NYSE American. This move addresses a technical requirement rather than fundamental business performance. Investors should hold to observe if the company can leverage the maintained listing to improve its operational and financial health, but further investment should be approached with caution given the circumstances leading to the split.

Keywords

reverse stock split, BiomX Inc., common stock, NYSE American, corporate governance, stockholders meeting, certificate of incorporation, equity awards, warrants, biotechnology